Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Los

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|October 15, 2009
New, exciting developments in experimental therapies in the early 21st centuryMarek Los
Cancer Biology & Therapy|September 14, 2006
Important differences between topoisomerase-I and -II targeting agentsShantanu Banerji, Marek Los
Cell Cycle (Georgetown, Tex.)|July 10, 2009
Catching chromatin relaxation in act by flow cytometryMarek Los, Klaus Schulze-Osthoff
Cancer Biology & Therapy|August 14, 2008
The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapySoumya Panigrahi, Thomas Klonisch, Marek Los
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|March 26, 2009
Switching Akt: from survival signaling to deadly responseMarek Los, Subbareddy Maddika, Bettina Erb, et al.
Current Medicinal Chemistry|February 10, 2009
Obesity: pathophysiology and clinical managementTatiana Gurevich-Panigrahi, Soumya Panigrahi, Emilia Wiechec, et al.
Experimental Oncology|July 27, 2004
Caspases and cancer: mechanisms of inactivation and new treatment modalitiesAleksei Philchenkov, Michael Zavelevich, Tadeusz J Kroczak, et al.
Current Medicinal Chemistry|January 29, 2008
Autoimmunity and apoptosis--therapeutic implicationsIran Rashedi, Soumya Panigrahi, Peyman Ezzati, et al.
European Journal of Pharmacology|December 16, 2006
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cellsMohammad Hashemi, Saeid Ghavami, Mehdi Eshraghi, et al.
Biologics : Targets & Therapy|August 27, 2009
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancerElizabeth S Henson, James B Johnston, Marek Los, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|October 15, 2009
New, exciting developments in experimental therapies in the early 21st centuryMarek Los
Cancer Biology & Therapy|September 14, 2006
Important differences between topoisomerase-I and -II targeting agentsShantanu Banerji, Marek Los
Cell Cycle (Georgetown, Tex.)|July 10, 2009
Catching chromatin relaxation in act by flow cytometryMarek Los, Klaus Schulze-Osthoff
Cancer Biology & Therapy|August 14, 2008
The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapySoumya Panigrahi, Thomas Klonisch, Marek Los
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|March 26, 2009
Switching Akt: from survival signaling to deadly responseMarek Los, Subbareddy Maddika, Bettina Erb, et al.
Current Medicinal Chemistry|February 10, 2009
Obesity: pathophysiology and clinical managementTatiana Gurevich-Panigrahi, Soumya Panigrahi, Emilia Wiechec, et al.
Experimental Oncology|July 27, 2004
Caspases and cancer: mechanisms of inactivation and new treatment modalitiesAleksei Philchenkov, Michael Zavelevich, Tadeusz J Kroczak, et al.
Current Medicinal Chemistry|January 29, 2008
Autoimmunity and apoptosis--therapeutic implicationsIran Rashedi, Soumya Panigrahi, Peyman Ezzati, et al.
European Journal of Pharmacology|December 16, 2006
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cellsMohammad Hashemi, Saeid Ghavami, Mehdi Eshraghi, et al.
Biologics : Targets & Therapy|August 27, 2009
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancerElizabeth S Henson, James B Johnston, Marek Los, et al.
Pageof 6